Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 25962
MIM: 616447
HGNC: 24500
Ensembl: ENSG00000164944
Variants:
dbSNP: 25962
ClinVar: 25962
TCGA: ENSG00000164944
COSMIC: VIRMA
RNA/Proteins
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38224863 | 2024 | KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells. | 0 |
| 38531807 | 2024 | Inhibin A contributes to the tumorigenesis of oral squamous cell carcinoma by KIAA1429-mediated m6A modification. | 0 |
| 39060874 | 2024 | KIAA1429 increases FOXM1 expression through YTHDF1-mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma. | 0 |
| 38224863 | 2024 | KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells. | 0 |
| 38531807 | 2024 | Inhibin A contributes to the tumorigenesis of oral squamous cell carcinoma by KIAA1429-mediated m6A modification. | 0 |
| 39060874 | 2024 | KIAA1429 increases FOXM1 expression through YTHDF1-mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma. | 0 |
| 36326914 | 2023 | N(6)-methyladenosine (m(6)A) writer KIAA1429 accelerates gastric cancer oxaliplatin chemoresistance by targeting FOXM1. | 4 |
| 36420693 | 2023 | KIAA1429 mediates epithelial mesenchymal transition in sorafenib-resistant hepatocellular carcinoma through m6A methylation modification. | 4 |
| 36463391 | 2023 | m6A 'writer' KIAA1429 regulates the proliferation and migration of endothelial cells in atherosclerosis. | 2 |
| 36493511 | 2023 | KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m(6)A-dependent manner. | 18 |
| 36691046 | 2023 | CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m(6)A) modification. | 4 |
| 37028765 | 2023 | VIRMA promotes nasopharyngeal carcinoma, tumorigenesis, and metastasis by upregulation of E2F7 in an m6A-dependent manner. | 3 |
| 37368192 | 2023 | Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner. | 3 |
| 37391589 | 2023 | VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization. | 1 |
| 37606975 | 2023 | Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy. | 3 |
Citation
Dessen P
VIRMA (vir like m6A methyltransferase associated)
Atlas Genet Cytogenet Oncol Haematol. 2017-09-01
Online version: http://atlasgeneticsoncology.org/gene/79208/virma-(vir-like-m6a-methyltransferase-associated)
